A. Kiliç Et Al. , "Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation," SSIEM Annual Symposium , no.1418955, Germany, 2022
Kiliç, A. Et Al. 2022. Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation. SSIEM Annual Symposium , (Germany).
Kiliç, A., BİBEROĞLU, G., ÖKTEM, R. M., İNCİ, A., Aydogdu, S., Udgu Isik, B., ... IŞIK GÖNÜL, İ.(2022). Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation . SSIEM Annual Symposium, Germany
Kiliç, AYŞE Et Al. "Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation," SSIEM Annual Symposium, Germany, 2022
Kiliç, AYŞE Et Al. "Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation." SSIEM Annual Symposium , Germany, 2022
Kiliç, A. Et Al. (2022) . "Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation." SSIEM Annual Symposium , Germany.
@conferencepaper{conferencepaper, author={AYŞE KILIÇ Et Al. }, title={Retargeting phenylbutyrate, ursodeoxycholic acid, pyrimethamine and betaine for beta-glucocerebrosidaserecovery in gaucher disease fibroblasts resulting from homozygous p.L483P mutation}, congress name={SSIEM Annual Symposium}, city={}, country={Germany}, year={2022}}